| Crimean–Congo hemorrhagic fever |
| Virus classification |
| Group: |
Group V ((-)ssRNA) |
| Order: |
Unassigned |
| Family: |
Bunyaviridae |
| Genus: |
Nairovirus |
| Crimean-Congo hemorrhagic fever |
| Classification and external resources |
Isolated male patient diagnosed with Crimean-Congo hemorrhagic fever |
| ICD-10 |
A98.0 |
| ICD-9 |
065.0 |
| DiseasesDB |
31969 |
| MedlinePlus |
article |
| eMedicine |
830594/ |
Crimean–Congo hemorrhagic fever (CCHF) is a widespread tick-borne viral disease, a zoonosis of domestic animals and wild animals, that may affect humans. The pathogenic virus, especially common in East and West Africa, is a member of the Bunyaviridae family of RNA viruses. Clinical disease is rare in infected mammals, but commonly severe in infected humans, with a 30% mortality rate. Outbreaks of illness are usually attributable to handling infected animals or people.
|
Contents
- 1 Signs and symptoms
- 2 Virology
- 2.1 Vectors
- 2.2 Receptors
- 3 Prevention
- 4 Treatment
- 5 Epidemiology
- 6 History
- 7 References
- 8 External links
|
Signs and symptoms [edit]
Typically, after a 1–3 day incubation period following a tick bite (5–6 days after exposure to infected blood or tissues), flu-like symptoms appear, which may resolve after one week. In up to 75% of cases, however, signs of hemorrhage appear within 3–5 days of the onset of illness in case of bad containment of the first symptoms: first mood instability, agitation, mental confusion and throat petechiae, then soon nosebleeds, bloody urine and vomiting, and black stools. The liver becomes swollen and painful. Disseminated intravascular coagulation may occur as well as acute kidney failure and shock, and sometimes acute respiratory distress syndrome. Patients usually begin to show signs of recovery after 9–10 days from when the symptoms appear, however 30% of the cases result in death on the second week of the illness.
Virology [edit]
The virus is a member of the genus Nairovirus, family Bunyaviridae. The genome is circular, ambisense RNA in three parts - Small (S), Middle (M) and Large (L). The L segment is 11-14.4 kilobases in length while the M and S segements are 4.4-6.3 and 1.7-2.1 kilobases long respectively. The L segment encodes the RNA polymerase; the M segment encodes the envelope proteins (Gc and Gn); and the S segment encodes the nucleocapsid protein. The envelope protein is initially translated as a glycoprotein precursor which is then cleaved into two smaller proteins.
The virons are 80-120 nanometers (nm) in diameter and are pleomorphic. There are no host ribosomes within the viron. Each viron contains three copies of the genome. The envelope is single layered and is formed from a lipid bilayer 5 nm thick. It has no protrusions. The envelope proteins form small projections ~5-10 nm long. The nucleocapsids are filamentous and circular with a length of 200-3000 nm.
Based on the sequence data seven genotypes have been recognised: Africa 1 (Senegal), Africa 2 (Democratic Republic of the Congo and South Africa), Africa 3 (southern and western Africa), Europe 1 (Albania, Bulgaria, Kosovo, Russia and Turkey), Europe 2 (Greece), Asia 1 (the Middle East, Iran and Pakistan) and Asia 2 (China, Kazakhstan, Tajikistan and Uzbekistan).
This virus appears to have evolved 3100–3500 years ago.[1] The mutation rates for the three parts of the genome were estimated to be: 1.09 x 10−4, 1.52 x 10−4 and 0.58 x 10−4 substitutions/site/year for the S, M, and L segments respectively.
Vectors [edit]
The virus has been isolated from at least 31 different species of ticks from the genera Haemaphysalis and Hyalomma.[2] Sporadic infection of people is usually caused by Hyalomma tick bite. Clusters of illness typically appear after people treat, butcher or eat infected livestock, particularly ruminants and ostriches. Outbreaks have occurred in clinical facilities where health workers have been exposed to infected blood and fomites. The causative organism is found in Asia, Eastern Europe, the Middle East, a belt across central Africa and South Africa and Madagascar (see map [3]) The main environmental reservoir for the virus is small mammals (particularly European Hare, Middle-African hedgehogs and multimammate rats). Ticks carry the virus to domestic animal stock. Sheep, goats and cattle develop high titers of virus in blood, but tend not to fall ill. Birds are generally resistant with the exception of ostriches.
Tick species that have been identified as infected with this virus include Argas reflexus, Hyalomma anatolicum, Hyalomma detritum, Hyalomma marginatum marginatum and Rhipicephalus sanguineus.Both working with humans and animals infected from Congo-Crimean Hemorrhagic fever usually transmit the virus to other humans.
Receptors [edit]
The cell surface protein nucleolin has been identified as a putative receptor for this virus.[4]
Prevention [edit]
Where mammalian tick infection is common, agricultural regulations require de-ticking farm animals before transportation or delivery for slaughter. Personal tick avoidance measures are recommended, such as use of insect repellents, adequate clothing and body inspection for adherent ticks.
When feverish patients with evidence of bleeding require resuscitation or intensive care, body substance isolation precautions should be taken.
The United States armed forces maintain special stocks of ribavirin to protect personnel deployed to Afghanistan and Iraq from CCHF.
Vaccine [edit]
Since the 1970s, several vaccine trials around the world against CCHF have been scrapped due to high toxicity.
In 2011, a Turkish research team led by Erciyes University has succeed to develop the first non-toxic preventive CCHF-vaccine in lab trials. The vaccine is pending approval by the FDA.[5]
Treatment [edit]
Treatment is primarily symptomatic and supportive, as there is no established specific treatment. Ribavirin is effective in vitro[6] and has been used during outbreaks,[7] but there is no trial evidence to support its use.
A Turkish research team led by Refik Saydam Health Institute has developed treatment-serum derived from blood of several CCHF-patients, which have been proven to be 90% effective in CCHF-patients.[8]
Epidemiology [edit]
During the summers of 1944 and 1945 over 200 cases of an acute, hemorrhagic, febrile illness occurred in Soviet troops rescuing the harvest following the ethnic cleansing of the Crimean Tatars.
On July 28, 2005 authorities reported 41 cases of CCHF in Turkey's Yozgat Province, with one death. As of August 2008, a total of 50 people were reported to have lost their lives in various cities in Turkey due to CCHF. 3128 Crimean–Congo hemorrhagic fever cases with 5% of case-fatality rate have been reported by the Ministry of Health of Turkey between 2002-2008.
On May 27, 2010 Hospitals reported 70 cases of CCHF in Kosovo's Kosovo Polje, with 4 deaths reported so far. The Authorities are not able to deal with the disease because of the lack of advanced medication.
In September 2010 an outbreak has been reported in Pakistan's Khyber Pakhtunkhwa province. Poor diagnosis and record keeping has caused the extent of the outbreak to be uncertain, though some reports indicate over 100 cases, with a case-fatality rate above 10%.
In January 2011, the disease has been reported in Gujarat, India, with 4 reported deaths, which consisted of the patient along with the doctor and the nurse who treated the patient.[9]
As of May 2012, 71 people are reported to have contracted the disease in Iran, resulting in 8 fatalities.[10]
In October 2012, a British man died from the disease at the Royal Free Hospital in London. He had earlier been admitted to Gartnavel General Hospital in Glasgow after returning on a flight from Kabul in Afghanistan.[11]
History [edit]
A case reported in the 12th century of a hemorrhagic disease from what is now Tajikistan may have been the first known case of Crimean–Congo hemorrhagic fever. Soviet scientists first identified the disease they called Crimean hemorrhagic fever in 1944 and established its viral etiology by passage of the virus through human "volunteers" (fatality rate unreported), but were unable to isolate the agent at that time.[12] In June 1967, Soviet virologist Mikhail Chumakov registered an isolate from a fatal case that occurred in Samarkand (on the ancient Silk Road in Central Asia, not the Crimea) in the Catalogue of Arthropod-borne Viruses.[13] Four months earlier, virologists Jack Woodall, D Simpson and others had published initial reports[14][15] on a virus they called the Congo virus, first isolated in 1956 by physician Ghislaine Courtois, head of the Provincial Medical Laboratory, Stanleyville, Belgian Congo. Strain V3010, isolated by Courtois, was sent to the Rockefeller Foundation Virus Laboratory (RFVL) in New York City and found to be identical to another strain from Uganda, but to no other named virus at that time. Chumakov later sent his strain to the RFVL, where it was found to be identical to the Congo virus.[16] The International Committee on Taxonomy of Viruses proposed the name Congo-Crimean hemorrhagic fever virus, but the Soviets insisted on Crimean–Congo hemorrhagic fever virus. Against all principles of scientific nomenclature based on priority of publication, it was adopted as the official name in 1973 in possibly the first instance of a virus losing its name to politics and the Cold War.[citation needed] However, since then Congo-Crimean or just Congo virus has been used in many reports, which would be missed in searches of medical databases using the official name. These reports include records of the occurrence of the virus or antibodies to the virus from Greece, Portugal, South Africa, Madagascar (the first isolation from there), the Maghreb, Dubai, Saudi Arabia, Kuwait and Iraq.[17][18][19]
References [edit]
- ^ Carroll SA, Bird BH, Rollin PE, Nichol ST (2010) Ancient common ancestry of Crimean-Congo hemorrhagic fever virus. Mol Phylogenet Evol 55(3):1103-1110
- ^ Mehravaran A, Moradi M, Telmadarraiy Z, Mostafavi E, Moradi AR, Khakifirouz S, Shah-Hosseini N, Varaie FS, Jalali T, Hekmat S, Ghiasi SM, Chinikar S (2012) Molecular detection of Crimean-Congo haemorrhagic fever (CCHF) virus in ticks from southeastern Iran. Ticks Tick Borne Dis pii: S1877-959X(12)00064-7. doi: 10.1016/j.ttbdis.2012.06.006
- ^ Map
- ^ Xiao, X.; Feng, Y.; Zhu, Z.; Dimitrov, D. S. (2011). "Identification of a putative Crimean-Congo hemorrhagic fever virus entry factor". Biochem. Biophys. Res. Commun. 411 (2): 253–258. doi:10.1016/j.bbrc.2011.06.109. PMID 21723257.
- ^ http://gundem.milliyet.com.tr/keneye-asi-mujdesi/gundem/gundemdetay/25.05.2012/1545014/default.htm
- ^ Watts DM, Ussery MA, Nash D, Peters CJ. (1989). "Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin". Am J Trop Med Hyg. 41 (5): 581–5. PMID 2510529.
- ^ Ergönül Ö, Celikbas A, Dokuzoguz B, et al. (2004). "The chacteristics of Crimean-Congo hemorrhagic fever in a recent outbreak in Turkey and the impact of oral ribavirin therapy". Clin Infect Dis 39 (2): 285–9. doi:10.1086/422000. PMID 15307042.
- ^ http://www.zaman.com.tr/haber.do?haberno=1192228&title=kirim-kongonun-serumunu-turk-doktorlar-uretti
- ^ http://www.indianexpress.com/news/deadly-virus-makes-first-appearance-in-india-kills-three-in-gujarat originated from sanand /739292/
- ^ http://edition.presstv.ir/detail/105532.html
- ^ http://www.bbc.co.uk/news/uk-scotland-glasgow-west-19856504
- ^ Chumakov, 1947 INCOMPLETE
- ^ Chumakov MP, Butenko AM, Shalunova NV, Mart'ianova LI, Smirnova SE, Bashkirtsev IuN, Zavodova TI, Rubin SG, Tkachenko EA, Karmysheva VIa, Reingol'd VN, Popov GV, Savinov AP (May–June 1968). "New data on the viral agent of Crimean hemorrhagic fever". Vopr Virusol (in Russian) 13 (3): 377. PMID 4235803.
- ^ Simpson DI, Knight EM, Courtois G, Williams MC, Weinbren MP, Kibukamusoke JW (February 1967). "Congo virus: a hitherto undescribed virus occurring in Africa. I. Human isolations—clinical notes". East Afr Med J 44 (2): 86–92. PMID 6040759.
- ^ Woodall JP, Williams MC, Simpson DI (February 1967). "Congo virus: a hitherto undescribed virus occurring in Africa. II. Identification studies". East Afr Med J 44 (2): 93–8. PMID 6068614.
- ^ Casals J (May 1969). "Antigenic similarity between the virus causing Crimean hemorrhagic fever and Congo virus". Proc Soc Exp Biol Med 131 (1): 233–6. PMID 5770109.
- ^ Crowcroft NS, Morgan D, Brown D (March 2002). "Viral haemorrhagic fevers in Europe—effective control requires a co-ordinated response". Euro Surveill 7 (3): 31–2. PMID 12631941.
- ^ Al-Tikriti SK, Al-Ani F, Jurji FJ, Tantawi H, Al-Moslih M, Al-Janabi N, Mahmud MI, Al-Bana A, Habib H, Al-Munthri H, Al-Janabi S, AL-Jawahry K, Yonan M, Hassan F, Simpson DI (1981). "Congo/Crimean haemorrhagic fever in Iraq". Bull World Health Organ 59 (1): 85–90. PMC 2396030. PMID 6790183.
- ^ Okorie TG (March 1991). "Comparative studies on the vector capacity of the different stages of Amblyomma variegatum Fabricius and Hyalomma rufipes Koch for Congo virus, after intracoelomic inoculation". Vet Parasitol 38 (2–3): 215–23. PMID 1907050.
External links [edit]
- Ergönül O. (2006). "Crimean-Congo haemorrhagic fever". Lancet Infect Dis 6 (4): 203–214. doi:10.1016/S1473-3099(06)70435-2. PMID 16554245.
- World Health Organization Fact Sheet
|
Zoonotic viral diseases (A80–B34, 042–079)
|
|
| Arthropod-borne |
| Mosquito-borne |
| Bunyaviridae |
- Arbovirus encephalitides: La Crosse encephalitis
- California encephalitis
- Viral hemorrhagic fevers: Rift Valley fever
|
|
| Flaviviridae |
- Arbovirus encephalitides: Japanese encephalitis
- Australian encephalitis
- Saint Louis encephalitis
- West Nile fever
- Viral hemorrhagic fevers: Dengue fever
- Yellow fever
- ZIKV
|
|
| Togaviridae |
- Arbovirus encephalitides: Eastern equine encephalomyelitis
- Western equine encephalomyelitis
- Venezuelan equine encephalomyelitis
- Chikungunya
- O'Nyong-nyong fever
- Ross River fever
|
|
|
| Tick-borne |
| Bunyaviridae |
- Viral hemorrhagic fevers: Crimean-Congo hemorrhagic fever
|
|
| Flaviviridae |
- Arbovirus encephalitides: Tick-borne encephalitis
- Powassan encephalitis
- Viral hemorrhagic fevers: Omsk hemorrhagic fever
- Kyasanur forest disease
- Langat virus (LGTV)
|
|
| Reoviridae |
|
|
|
|
| Mammal-borne |
| Rodent-borne |
| Arenaviridae |
- Viral hemorrhagic fevers: Lassa fever
- Venezuelan hemorrhagic fever
- Argentine hemorrhagic fever
- Brazilian hemorrhagic fever
- Bolivian hemorrhagic fever
- LUJV
- CHPV
|
|
| Bunyaviridae |
- Hemorrhagic fever with renal syndrome
- Hantavirus pulmonary syndrome
|
|
|
| Bat-borne |
| Filoviridae |
- Viral hemorrhagic fevers: Ebola virus disease
- Marburg virus disease
|
|
| Rhabdoviridae |
|
|
| Paramyxoviridae |
|
|
|
| Multiple vectors |
|
|
|
|
|
|
cutn/syst (hppv/hiva, infl/zost/zoon)/epon
|
drug (dnaa, rnaa, rtva, vacc)
|
|
|
|
|
Zoonosis: Tick-borne diseases and mite-borne diseases
|
|
Bacterial infection
(all G-) |
|
Rickettsiales
|
- Rocky Mountain spotted fever
- Ehrlichiosis (Human granulocytic, Human monocytic)
- Boutonneuse fever
|
|
|
Spirochaete
|
- Lyme disease
- Relapsing fever
|
|
|
Thiotrichales
|
|
|
|
| Viral infection |
- Colorado tick fever
- Tick-borne encephalitis
- Crimean-Congo hemorrhagic fever
- Omsk hemorrhagic fever
- Kyasanur forest disease
- Powassan encephalitis
- Heartland virus
|
|
| Protozoan infection |
|
|
| Neurotoxin |
|
|
| General |
|
|
| Vectors |
|
Ticks
|
- Ixodes: Ixodes scapularis
- Ixodes holocyclus
- Ixodes pacificus
- Ixodes ricinus
- Dermacentor: Dermacentor variabilis
- Dermacentor andersoni
- Amblyomma: Amblyomma americanum
- Amblyomma cajennense
- Ornithodoros: Ornithodoros moubata
- Ornithodoros hermsi
- other: Rhipicephalus sanguineus
|
|
|
Mites
|
- Leptotrombidium deliense
- Liponyssoides sanguineus
|
|
|
|
|
|
